BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 9659276)

  • 1. Value of assessing parathyroid hormone-like activity in a case of extreme hypercalcaemia.
    Ranganath L; Jamal H; Jones L; Goddard PF
    J Clin Pathol; 1998 Mar; 51(3):257-8. PubMed ID: 9659276
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Parathyroid hormone and parathyroid hormone-related protein in the investigation of hypercalcaemia in two hospital populations.
    Walls J; Ratcliffe WA; Howell A; Bundred NJ
    Clin Endocrinol (Oxf); 1994 Oct; 41(4):407-13. PubMed ID: 7955450
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Survival in hypercalcaemic patients with cancer and co-existing primary hyperparathyroidism.
    Hutchesson AC; Bundred NJ; Ratcliffe WA
    Postgrad Med J; 1995 Jan; 71(831):28-31. PubMed ID: 7708588
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Parathyroid hormone-related protein as a cause of hypercalcemia in a B-cell type malignant lymphoma.
    Wada S; Kitamura H; Matsuura Y; Katayama Y; Ohkawa H; Kugai N; Motoyoshi K; Fuse Y; Nagata N
    Intern Med; 1992 Aug; 31(8):968-72. PubMed ID: 1335805
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Circulating vitamin D metabolites and hypercalcaemia of malignancy.
    Ralston SH; Cowan RA; Robertson AG; Gardner MD; Boyle IT
    Acta Endocrinol (Copenh); 1984 Aug; 106(4):556-63. PubMed ID: 6548074
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Refractory hypercalcaemia secondary to parathyroid carcinoma: response to high-dose denosumab.
    Karuppiah D; Thanabalasingham G; Shine B; Wang LM; Sadler GP; Karavitaki N; Grossman AB
    Eur J Endocrinol; 2014 Jul; 171(1):K1-5. PubMed ID: 24743399
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Primary hyperparathyroidism or hypercalcaemia of malignancy?
    Birkeland KI; Gallefoss F; Olsson S; Haug E
    Scand J Clin Lab Invest; 1992 Jun; 52(4):347-9. PubMed ID: 1439519
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Parathyroid hormone and parathyroid hormone related protein assays in the investigation of hypercalcemic patients in hospital in a Chinese population.
    Lee JK; Chuang MJ; Lu CC; Hao LJ; Yang CY; Han TM; Lam HC
    J Endocrinol Invest; 1997; 20(7):404-9. PubMed ID: 9309539
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Malignant hypercalcemia after treatment of breast cancer].
    Bernard JD; Rimailho J; Pourrut JC; Hoff J; Bècue J
    J Gynecol Obstet Biol Reprod (Paris); 1992; 21(7):775-7. PubMed ID: 1469233
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Parathyroid hormone-related protein, bone metastases and hypercalcaemia of malignancy.
    Bundred NJ; Walls J; Ratcliffe WA
    Ann R Coll Surg Engl; 1996 Jul; 78(4):354-8. PubMed ID: 8712650
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Incomplete suppression of parathyroid hormone activity in sarcoidosis presenting with hypercalcaemia.
    Ghose RR; Woodhead JS; Brown RC
    Postgrad Med J; 1983 Sep; 59(695):572-4. PubMed ID: 6634558
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hypercalcemic complication in patients with oral squamous cell carcinoma.
    Iwase M; Takemi T; Manabe M; Nagumo M
    Int J Oral Maxillofac Surg; 2003 Apr; 32(2):174-80. PubMed ID: 12729778
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hypercalcaemia secondary to ectopic parathyroid hormone expression in an adolescent with metastatic alveolar rhabdomyosarcoma.
    Brooks R; Lord C; Davies JH; Gray JC
    Pediatr Blood Cancer; 2018 Jan; 65(1):. PubMed ID: 28843052
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Serum parathyroid hormone levels in the hypercalcaemia of urological malignant disease.
    Ramsay JW; Hendry WF
    J R Soc Med; 1986 Jun; 79(6):323-5. PubMed ID: 3723531
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Parathyroid hormone-related protein (PTH-rP)-associated hypercalcemia in a patient with an atypical chronic lymphocytic leukemia.
    Vlasveld LT; Pauwels P; Ermens AA; Aarnoudse WH; Ooms HW; Haak HR
    Neth J Med; 1999 Jan; 54(1):21-6. PubMed ID: 10048292
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Disappearing hypercalcaemia.
    Wood GM; Sidhu B; Saunders WA; Zalin AM; Heath DA
    Postgrad Med J; 1987 Sep; 63(743):741-4. PubMed ID: 3444796
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Incidence and prognostic significance of hypercalcaemia in B-cell non-Hodgkin's lymphoma.
    Majumdar G
    J Clin Pathol; 2002 Aug; 55(8):637-8. PubMed ID: 12147666
    [No Abstract]   [Full Text] [Related]  

  • 18. Follicular lymphoma presenting with hypercalcaemia: an unusual mechanism of hypercalcaemia.
    Martens P; Addissie B; Kumar R
    Acta Clin Belg; 2015 Jun; 70(3):200-3. PubMed ID: 25475431
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Humoral hypercalcemia of malignancy in squamous cell carcinoma of the skin: parathyroid hormone--related protein as a cause.
    Cisneros G; Lara LF; Crock R; Whittier FC
    South Med J; 2001 Mar; 94(3):329-31. PubMed ID: 11284521
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Parathyroid hormone-related protein as a tumour marker in humoral hypercalcaemia associated with occult malignancy.
    Hutchesson AC; Dunne F; Bundred NJ; Gee H; Ratcliffe WA
    Postgrad Med J; 1993 Aug; 69(814):640-2. PubMed ID: 7880211
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.